While the study did not directly assess the difference between radiation and immunotherapy sequencing, there was an important trend of improved responses for patients who received durvalumab closer to the chemoradiation administration.
← all excerpts
Challenges in synergizing radiotherapy with immunotherapy to unlock the abscopal effect in metastatic NSCLC: A systematic review.
1
—
—